Jennie Shuman, Consultant, Author at EverGlade Consulting - Page 2 of 3

Jennie Shuman, Consultant

Jennie Shuman, Consultant
DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations

Leave a Comment / DARPA, Emerging Technologies / By

Special Topic: Ag x BTO To defend against threats to America’s agricultural infrastructure, the Defense Advanced Research Projects Agency (DARPA) has launched a new Special Topic Area (STA) through its Biological Technologies Office (BTO). Known as Ag x BTO, this initiative seeks to catalyze innovative approaches to defending the U.S. agricultural system from chemical, biological, […]

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations Read More »

Medicine capsules global health with geometric pattern digital r

ARPA-H’s Proactive Health Office ISO Amendment 2

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

PROACTIVE HEALTH OFFICE – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) – ARPA-H-SOL-24-106 – Amendment 02: June 06, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has recently amended the Proactive Health Office (PHO) Innovative Solutions Opening (ISO). The PHO ISO invites novel and disruptive health innovations aimed at extending health spans and improving health

ARPA-H’s Proactive Health Office ISO Amendment 2 Read More »

Vaccine Research

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA

Leave a Comment / BARDA, Life Sciences / By

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA BAA-23-100-SOL-00004 – Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) In response to today’s evolving public health landscape, the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services (HHS) within the Administration for Strategic

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA Read More »

Superconductor microchip with blue overlay

Unlocking Scientific Breakthroughs for National Security: DARPA’s DSO Office-wide BAA

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

Broad Agency Announcement Defense Sciences Office (DSO) Office-wide BAA Defense Sciences Office HR001125S0013 Pioneering the Next Generation of Defense Research On June 3, 2025, the Defense Advanced Research Projects Agency (DARPA), through its Defense Sciences Office (DSO), announced an open solicitation under Broad Agency Announcement (BAA) HR001125S0013. This office-wide BAA serves as a mechanism for

Unlocking Scientific Breakthroughs for National Security: DARPA’s DSO Office-wide BAA Read More »

Two scientists in lab coats at a computer discussing their findings

DARPA’s RFI on Advanced Disease Outbreak Simulation

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

Advanced Disease Outbreaks Simulation Capabilities The Defense Advanced Research Projects Agency (DARPA) has issued a new Request for Information (RFI) titled “Advanced Disease Outbreaks Simulation Capabilities” (DARPA-SN-25-72). This announcement seeks insights from the research and development community on cutting-edge outbreak modeling tools to increase understanding of outbreak dynamics and improve future public health emergency preparedness.

DARPA’s RFI on Advanced Disease Outbreak Simulation Read More »

Close-up of Medical Ampoule Production Line at Modern Modern Pharmaceutical Factory. Glass Ampoules are being Filled. Medication Manufacturing Process.

DTRA’s RAVEN RFI Seeks Multivalent Vaccine Innovation

Leave a Comment / All Posts, DTRA, Life Sciences / By

Reimagining the Future of Vaccines: DTRA’s RAVEN RFI The Defense Threat Reduction Agency (DTRA), through its Joint Science and Technology Office (JSTO), has announced a new Request for Information (RFI) under the initiative titled Reimagining Available Vaccines and Envisioning Novelty (RAVEN). This RFI reflects DTRA’s responsibility to prepare the U.S. warfighter for current and emerging

DTRA’s RAVEN RFI Seeks Multivalent Vaccine Innovation Read More »

PROSPR program

Proactive Solutions for Prolonging Resilience Opportunity Announcement

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

The Foci of PROSPR ARPA-H-SOL-25-125, PROSPR The PROSPR solicitation outlines a comprehensive, multi-year program structured around the development, validation, and deployment of novel health technologies. The program is divided into three primary technical areas (TAs), each addressing a critical component of healthspan extension: TA1 focuses on developing a PROSPR Intrinsic Capacity (IC) score that quantifies

Proactive Solutions for Prolonging Resilience Opportunity Announcement Read More »

DARPA-SABER AI military applications battelfield systems

DARPA’s SABER Initiative to Secure AI on the Battlefield

Leave a Comment / AI, All Posts, DARPA, Emerging Technologies / By

Broad Agency Announcement Information Innovation Office Securing Artificial Intelligence for Battlefield Effective Robustness (SABER) – HR001125S0009 Securing AI on the Battlefield: DARPA’s SABER Initiative In an era where artificial intelligence (AI) is becoming an integral part of military operations, ensuring its security and resilience is paramount. The Defense Advanced Research Projects Agency (DARPA) has launched

DARPA’s SABER Initiative to Secure AI on the Battlefield Read More »

ARPA-H_RAPID rare disease diagnostics

RAPID Solicitation

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

RAPID_SOL_25_119_FINAL Overview The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). The RAPID program aims to significantly improve outcomes for people with rare diseases by reducing diagnostic delays by ≥50%, decreasing misdiagnosis rates, and expanding access to diagnostics. Beyond benefitting the treatment experience of

RAPID Solicitation Read More »

molecular science DARPA

Unlocking the Future of Microsystems: DARPA’s MICA Program

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

DARPA, Microsystems Induced CAtalysis (MICA) Program Overview of the MICA Program The Defense Advanced Research Projects Agency (DARPA) has recently announced a groundbreaking funding opportunity, titled “Microsystems Induced CAtalysis” (MICA). This Broad Agency Announcement (BAA) aims to enhance molecular science by creating advanced tools and techniques for controlling molecular catalysts using microsystems. This initiative goes

Unlocking the Future of Microsystems: DARPA’s MICA Program Read More »

antiviral therapeutics against filoviruses

New Opportunities with DRIVe: ReBooT and RePAIR Amendments

Leave a Comment / All Posts, BARDA, Life Sciences / By

Amendment 034 – DRIVe EZ BAA_ReBooT_RePAIR New Opportunities with DRIVe: ReBooT and RePAIR Amendments The Biomedical Advanced Research and Development Authority’s (BARDA) Division of Research, Innovation & Ventures (DRIVe) has announced updates to its Easy Broad Agency Announcement (EZ-BAA) with Amendment #034. This amendment reopens and revises the ReBooT (AOI #22) program and pauses the

New Opportunities with DRIVe: ReBooT and RePAIR Amendments Read More »

rapid medical countermeasure (MCM) RPP

MCDC Requests Prototype Projects

Leave a Comment / All Posts, JPEO, Life Sciences / By

MCDC 25-01 Innovative Drug Development Pipeline Methods for Rapid Medical Countermeasure (MCM) Development This solicitation from the Medical CBRN Defense Consortium (MCDC), in support of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) represents a Request for Prototype Proposals (RPP). This RPP (MCDC 25-01) calls for innovative drug development pipeline

MCDC Requests Prototype Projects Read More »

Scroll to Top